These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31361068)

  • 1. Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome.
    De Zio R; Gerbino A; Forleo C; Pepe M; Milano S; Favale S; Procino G; Svelto M; Carmosino M
    J Cell Mol Med; 2019 Sep; 23(9):6331-6342. PubMed ID: 31361068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
    J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
    Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
    Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
    Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
    PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
    Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
    Fujii Y; Matsumoto Y; Hayashi K; Ding WG; Tomita Y; Fukumoto D; Wada Y; Ichikawa M; Sonoda K; Ozawa J; Makiyama T; Ohno S; Yamagishi M; Matsuura H; Horie M; Itoh H
    J Cardiol; 2017 Jul; 70(1):74-79. PubMed ID: 27816319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome.
    Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Kaneda T; Mabuchi H; Sumita R; Oshima T; Hoshi N; Higashida H
    Clin Sci (Lond); 2005 Feb; 108(2):143-50. PubMed ID: 15500450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANK2 functionally interacts with KCNH2 aggravating long QT syndrome in a double mutation carrier.
    Gessner G; Runge S; Koenen M; Heinemann SH; Koenen M; Haas J; Meder B; Thomas D; Katus HA; Schweizer PA
    Biochem Biophys Res Commun; 2019 May; 512(4):845-851. PubMed ID: 30929919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and clinical characterization of a novel homozygous KCNH2 missense variant in the pore region of Kv11.1 leading to a viable but severe long-QT syndrome.
    Delinière A; Jaupart L; Janin A; Millat G; Boulin T; Andrini O; Chevalier P
    Gene; 2024 Mar; 897():148076. PubMed ID: 38086455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing.
    Muñoz-Esparza C; García-Molina E; Salar-Alcaraz M; Peñafiel-Verdú P; Sánchez-Muñoz JJ; Martínez Sánchez J; Cabañas-Perianes V; Valdés Chávarri M; García Alberola A; Gimeno-Blanes JR
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):861-8. PubMed ID: 25819988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
    Delisle BP; Slind JK; Kilby JA; Anderson CL; Anson BD; Balijepalli RC; Tester DJ; Ackerman MJ; Kamp TJ; January CT
    Mol Pharmacol; 2005 Jul; 68(1):233-40. PubMed ID: 15851652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next generation sequencing revealed a novel deletion-frameshift mutation of KCNH2 gene in a Chinese Han family with long QT syndrome: A case report and review of Chinese cases.
    Du F; Wang G; Wang D; Su G; Yao G; Zhang W; Su G
    Medicine (Baltimore); 2020 Apr; 99(16):e19749. PubMed ID: 32311972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of KCNH2 gene mutations of type 2 long QT syndrome in larval zebrafish using microscopy and electrocardiography.
    Tanaka Y; Hayashi K; Fujino N; Konno T; Tada H; Nakanishi C; Hodatsu A; Tsuda T; Nagata Y; Teramoto R; Yoshida S; Nomura A; Kawashiri MA; Yamagishi M
    Heart Vessels; 2019 Jan; 34(1):159-166. PubMed ID: 30047011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intronic mutation causes long QT syndrome.
    Zhang L; Vincent GM; Baralle M; Baralle FE; Anson BD; Benson DW; Whiting B; Timothy KW; Carlquist J; January CT; Keating MT; Splawski I
    J Am Coll Cardiol; 2004 Sep; 44(6):1283-91. PubMed ID: 15364333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interdomain KCNH2 Mutation Produces an Intermediate Long QT Syndrome.
    Osterbur ML; Zheng R; Marion R; Walsh C; McDonald TV
    Hum Mutat; 2015 Aug; 36(8):764-73. PubMed ID: 25914329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.
    Kanters JK; Skibsbye L; Hedley PL; Dembic M; Liang B; Hagen CM; Eschen O; Grunnet M; Christiansen M; Jespersen T
    Scand J Clin Lab Invest; 2015; 75(8):699-709. PubMed ID: 26403377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.